Terms: = Head and neck cancer AND SPEN, Q96T58, 23013, ENSG00000065526, SHARP, RP1-134O19_1, MINT, KIAA0929 AND Prognosis
11873 results:
1. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
Fang Q; Yuan J; Zhang X; Dai L; Luo R
BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Ability of Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shete MV; Shete AV; Buva K; Channe PP; Sapkal R; Nerkar Rajbhoj A
Asian Pac J Cancer Prev; 2024 May; 25(5):1477-1486. PubMed ID: 38809619
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
[TBL] [Abstract] [Full Text] [Related]
4. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
Yu J; Liu H; Wu Y
BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
[TBL] [Abstract] [Full Text] [Related]
5. Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis.
Guo H; Wang T
Medicine (Baltimore); 2024 May; 103(21):e38160. PubMed ID: 38787991
[TBL] [Abstract] [Full Text] [Related]
6. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
; ; . PubMed ID: 38784388
[TBL] [Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next]